← Open Payments lookup

MICHAEL JONES: Open Payments

NPI 1972523991 · MEXICO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$553 in 34 payments from 8 companies in 2025. Trend: 2023 $659 · 2024 $477 · 2025 $553

Food & beverage: $553
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$177
Neurocrine BioSciences, Inc.9$138
ABBVIE INC.3$52
Vanda Pharmaceuticals Inc.3$49
Teva Pharmaceuticals USA, Inc.3$49
Axsome Therapeutics, Inc.2$34
Corcept Therapeutics2$32
Otsuka America Pharmaceutical, Inc.1$21

Products named: CAPLYTA, INGREZZA, VRAYLAR, FANAPT, AUSTEDO XR, Auvelity, Korlym, REXULTI.

Industry payments across MO — which companies pay providers there.